Week of December 19, 2023 | Vol. 12, Issue 49

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®

PR Newswire - Dec 10, 2023

Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers

Business Wire - Dec 11, 2023

ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas' LNP formulations

Recipharm - Dec 11, 2023

SystImmune, BMS Enter Potential $8.4B Strategic ADC Alliance

Contract Pharma - Dec 12, 2023

After swell of biopharma outrage, Supreme Court takes up high-profile mifepristone case

Fierce Pharma - Dec 13, 2023

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

PR Newswire - Dec 13, 2023

Alkermes to Sell Mfg. Facility in Ireland to Novo Nordisk for $92.5M

Contract Pharma - Dec 14, 2023

Done deal: Pfizer completes $43B acquisition of Seagen, doubling its oncology pipeline

Fierce Pharma - Dec 14, 2023

Nona Biosciences, Pfizer Enter Global ADC License Agreement

The White House - Dec 15, 2023

TANNER NEWS

Tanner | A Rare Affair | JPM Conference

We're excited to serve as a sponsor for A Rare Affair 2024, a wonderful evening of networking, wine and food hosted by Ultragenyx at the JP Morgan Healthcare Conference. We hope you will join us on January 7th. Learn more.